- Home
- GNLX vs HSPO Comparison
GNLX vs HSPO Comparison
Compare GNLX & HSPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- HSPO
- Stock Information
- Founded
- GNLX 2001
- HSPO 2014
- Country
- GNLX United States
- HSPO United States
- Employees
- GNLX N/A
- HSPO N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- HSPO Blank Checks
- Sector
- GNLX Health Care
- HSPO Finance
- Exchange
- GNLX Nasdaq
- HSPO Nasdaq
- Market Cap
- GNLX 85.0M
- HSPO 90.8M
- IPO Year
- GNLX 2023
- HSPO 2022
- Fundamental
- Price
- GNLX $3.13
- HSPO $11.42
- Analyst Decision
- GNLX Strong Buy
- HSPO
- Analyst Count
- GNLX 4
- HSPO 0
- Target Price
- GNLX $18.25
- HSPO N/A
- AVG Volume (30 Days)
- GNLX 80.9K
- HSPO 2.8K
- Earning Date
- GNLX 11-14-2024
- HSPO 01-01-0001
- Dividend Yield
- GNLX N/A
- HSPO N/A
- EPS Growth
- GNLX N/A
- HSPO 2.63
- EPS
- GNLX N/A
- HSPO 0.28
- Revenue
- GNLX $8,000.00
- HSPO N/A
- Revenue This Year
- GNLX N/A
- HSPO N/A
- Revenue Next Year
- GNLX N/A
- HSPO N/A
- P/E Ratio
- GNLX N/A
- HSPO $40.54
- Revenue Growth
- GNLX N/A
- HSPO N/A
- 52 Week Low
- GNLX $1.60
- HSPO $10.75
- 52 Week High
- GNLX $12.12
- HSPO $11.90
- Technical
- Relative Strength Index (RSI)
- GNLX 68.05
- HSPO 49.79
- Support Level
- GNLX $2.25
- HSPO $11.33
- Resistance Level
- GNLX $2.57
- HSPO $11.72
- Average True Range (ATR)
- GNLX 0.25
- HSPO 0.09
- MACD
- GNLX 0.06
- HSPO -0.01
- Stochastic Oscillator
- GNLX 71.31
- HSPO 15.79
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
About HSPO Horizon Space Acquisition I Corp.
Horizon Space Acquisition I Corp is a blank check company.